lumimeds tirzepatide Tirz Compounded Tirzepatide (GLP-1 / GIP)

Whats the difference between Ozempic, Wegovy, and Zepbound

Eli Lilly launches weight-loss drug Mounjaro in India after regulator approval

Abstract Introduction Recent pharmacological options for weight management include the glucagon-like peptide 1 (GLP-1) receptor agonists semaglutide and liraglutide, and the glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist tirzepatide, but head-to-head comparisons of all three of these interventions are lacking

Dont forget to list any allergies you have to medications or foods

However, clinical studies have shown promising results: Average Weight Loss: Clinical trials indicate that people using GLP-1 for weight loss typically lose around 15-20% of their body weight over a period of 68 weeks (approximately 1 year and 3 months), when combined with a reduced-calorie diet and increased physical activity

What should you not do while on semaglutide